Home » Newsletters » BioWorld

BioWorld

April 5, 2001

View Archived Issues

Other News To Note

Discovery Laboratories To Begin Second Surfaxin Pivotal Phase III

U.S. Genomics Raises $17M For Genome-Reading Platform

Repligen Reports Initial Results From Secretin Phase II In Autism

Myriad, Partners Initiate $185M Effort To Map Human Proteome

Xenon Placement Brings $45M For Work In 'Extreme Genetics'

In Autoimmunity, T Cells Needn't Kill Mistargeted 'Self' Antigens, Just Suppress Them, Wistar Finds